Pfizer-BioNTech vaccine shot stops covid spread – Israeli Study
|The Pfizer/ BioNTech jointly developed COVID-19 vaccine appeared to prevent the vast majority of recipients in Israel from being infected, Bloomberg reports after seeing a copy of a draft publication that was posted on Twitter and confirmed by a person familiar with the latest Israeli study.
Key takeaways
“The vaccine, which is being rolled out in a national immunization program that began Dec. 20, was 89.4% effective at preventing laboratory-confirmed infections.”
“If confirmed, the early results on lab-tested infections are encouraging because they indicate the vaccine may also prevent asymptomatic carriers from spreading the virus that causes Covid-19.“
“Israeli authorities on Saturday said the Pfizer-BioNTech shot was 99% effective at preventing deaths from the virus.”
Market reaction
The risk sentiment remains buoyed amid progress made in curbing the coronavirus spread globally and upbeat vaccine results.
The S&P 500 futures add 0.11% on the day to trade just above 3,900 while the US dollar index attempts a recovery from multi-day lows, still in the red around 90.30.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.